-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, there has been wave after wave of volume purchases, and China Procurement and Alliance Procurement have made moves one after another, and pharmaceutical companies are overwhelmed.
At the national level, the fifth batch of centralized procurement has been launched in many provinces, while at the local level, the top 80% of the drugs in the planned centralized procurement of Guangdong Province, the Heilongjiang Eight Provinces and Second District Alliance have launched 21 varieties of centralized procurement, and 11 provinces in Chongqing.
The alliance collects 53 varieties, and the Xinjiang "2+N" alliance collects 60 varieties.
.
.
The 30 billion market has changed! Foreign-funded enterprises dominate the screen, Hengrui and Qilu squeeze into the TOP10
Guangdong Province is an important drug sales area in China.
Annual sales trend of terminal chemical drugs in public hospitals in Guangdong Province (unit: 100 million yuan)
Source: The terminal competition pattern of public hospitals in key provinces and cities of Meinenet
From the perspective of manufacturers' sales structure, the total market share of TOP20 manufacturers exceeds 40%.
From the perspective of the therapeutic field, anti-tumor and immunomodulators are the top-selling category in the chemical drug market of public hospitals in Guangdong Province, leading the market with a market share of 26.
The general pattern of terminal chemical drugs in public hospitals in Guangdong Province in 2020
Source: The terminal competition pattern of public hospitals in key provinces and cities of Meinenet
Sales TOP20 is out! Three star drugs fell into the "sacred altar", four major products rose more than 30%
TOP20 general names of terminal chemical drugs in public hospitals in Guangdong Province in 2020
Source: The terminal competition pattern of public hospitals in key provinces and cities of Meinenet
Among the TOP20 general names of terminal chemical drugs in public hospitals in Guangdong Province, there are as many as 7 anti-tumor drugs, 3 plasma substitutes and infusions, and 2 proton pump inhibitors.
It is worth noting that the three Roche monoclonal antibodies (bevacizumab, rituximab, and trastuzumab) that have been on the list for many years still exist, while clopidogrel, atorvastatin, entecavir, etc.
From the perspective of sales changes, the sales of 12 generic drugs have achieved positive growth, and the sales of four drugs including human albumin, osimertinib, recombinant human coagulation factor, and ilaprazole have increased by more than 30%.
Iprazole is the exclusive innovative drug of Livzon Group.
15 varieties face the impact of the fifth batch of centralized procurement and 500 varieties of centralized procurement
On April 21, the Guangdong Provincial Medical Insurance Bureau issued a notice to solicit opinions on the implementation plan of Guangdong Pharmaceutical Group's bulk procurement.
Look again at the speech of Hu Jinglin, Director of the National Medical Insurance Administration, at the National Medical Insurance Work Conference in January 2021: All regions should focus on the centralized procurement of drugs outside the national procurement and the top 500 cost-ranking drugs, and explore non-overrated chemical drugs, Biopharmaceutical collection.
It can be seen that although there is no specific product list for the top 80% of Guangdong Province, the top 20 sales in Guangdong Province and the drugs in the 500 product list will undoubtedly become key targets, and relevant manufacturers should not be taken lightly.
The fifth batch of centralized procurement involves 60 varieties and 211 product specifications.
As for the list of 500 products that are hotly discussed in the industry, among the top 20 drug sales in Guangdong, bevacizumab, oxaliplatin, paclitaxel, sodium chloride, esomeprazole, trastuzumab, meropenem 15 drugs, including voriconazole, ilaprazole, tacrolimus, rituximab, docetaxel, peritoneal dialysate, dezocine, and low-molecular-weight heparin, are all included in the list of 500 varieties.
Among the 15 drugs, 4 of the fifth batch of planned collection varieties, including oxaliplatin, paclitaxel, esomeprazole, and docetaxel, can be eliminated, while bevacizumab, rituximab, The three major monoclonal antibodies, trastuzumab, have become the focus.
In addition, the products that are not in the top 20 in Guangdong drug sales, but have a large amount and a certain sales scale are also worthy of attention.
